FDAnews
www.fdanews.com/articles/132295-optimer-seeks-quick-green-light-from-fda-for-antibiotic-against-deadly-bug

Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug

November 30, 2010
San Diego-based Optimer Pharmaceuticals has spent more than $200 million and a dozen years of effort to get to the point where it can ask the FDA to clear its first product for sale on the U.S. market.
Xconomy